Ocunexus Therapeutics Funding: $65M Raised, Series A (2021)
Ocunexus Therapeutics is based in San Diego. It has raised $65M in total funding. Latest round: Series A.
Ocunexus Therapeutics funding overview
Ocunexus Therapeutics is based in San Diego. Ocunexus Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Ocunexus Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Domain Associates, Kleiner Perkins, Versant Ventures, Biopacificventures, GBS Venture Partners, Rusnanomedinvest. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Ocunexus Therapeutics funding
How much has Ocunexus Therapeutics raised?
Ocunexus Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Ocunexus Therapeutics?
Domain Associates, Kleiner Perkins, Versant Ventures, Biopacificventures, GBS Venture Partners, Rusnanomedinvest are named among the investors backing Ocunexus Therapeutics.
What was the latest Ocunexus Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2021.
Where is Ocunexus Therapeutics based?
Ocunexus Therapeutics is based in San Diego.
When did Ocunexus Therapeutics last raise?
The last disclosed Ocunexus Therapeutics round closed in January 2021 at Series A.
Ocunexus Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.
